Patients undergoing transcatheter aortic valve replacement (TAVR) have similar postoperative ischaemic and bleeding outcomes regardless of whether they take oral anticoagulants for atrial fibrillation or standard antiplatelet therapy, cardiologists at a Victorian centre have shown. In a prospective study conducted among patients having TAVR at the Monash Cardiovascular Research Centre, Melbourne, clinicians compared outcomes in ...
Anticoagulant therapy proves safe and effective for AF patients post TAVR
By Michael Woodhead
27 Apr 2018